The clinical utility of serum free light chain and heavy/light chain assays in monitoring disease activity in patients with IgG myeloma after achieving a deep response

Publisher: John Wiley & Sons Inc

E-ISSN: 2050-0904|6|1|96-102

ISSN: 2050-0904

Source: Clinical Case Reports, Vol.6, Iss.1, 2018-01, pp. : 96-102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content